The hepatocyte epidermal growth factor receptor ( EGFR ) pathway regulates the cellular interactome within the liver fibrotic niche
The Journal of Pathology · 2024
DOI: 10.1002/path.6299 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Pathology, 2024. Verfasst von Ester Gonzalez-Sanchez und 18 weiteren Autor:innen. Beteiligte Einrichtung: Oncobell Program, Bellvitge Biomedical Research Institute - IDIBELL, L'Hospitalet, Barcelona, Spain. Hauptthemen laut MEDLINE: ErbB Receptors, Hepatocytes, Signal Transduction, Carbon Tetrachloride. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CIBEREHD, National Biomedical Research Institute on Liver and Gastrointestinal Diseases, CERCA Programme/Generalitat de Catalunya, Fundacion Ramon Areces.
Abstract (Originalsprache)
Liver fibrosis is the consequence of chronic liver injury in the presence of an inflammatory component. Although the main executors of this activation are known, the mechanisms that lead to the inflammatory process that mediates the production of pro‐fibrotic factors are not well characterized. Epidermal growth factor receptor (EGFR) signaling in hepatocytes is essential for the regenerative processes of the liver; however, its potential role in regulating the fibrotic niche is not yet clear. Our group generated a mouse model that expresses an inactive truncated form of the EGFR specifically in hepatocytes (ΔEGFR mice). Here, we have analyzed the response of WT and ΔEGFR mice to chronic treatment with carbon tetrachloride (CCl 4 ), which induces a pro‐inflammatory and fibrotic process in the liver. The results indicated that the hallmarks of liver fibrosis were attenuated in CCl 4 ‐treated ΔEGFR mice when compared with CCl 4 ‐treated WT mice, coinciding with a faster resolution of the fibrotic process and ameliorated damage. The absence of EGFR activity in hepatocytes induced changes in the pattern of immune cells in the liver, with a notable increase in the population of M2 macrophages, more related to fibrosis resolution, as well as in the population of lymphocytes related to eradication of the damage. Transcriptome analysis of hepatocytes, and secretome studies of extracellular media from in vitro experiments, allowed us to elucidate the specific molecular mechanisms regulated by EGFR that mediate hepatocyte production of both pro‐fibrotic and pro‐inflammatory mediators; these have consequences for the deposition of extracellular matrix proteins, as well as for the immune microenvironment. Overall, our study uncovered novel mechanistic insights regarding EGFR kinase‐dependent actions in hepatocytes that reveal its key role in chronic liver damage. © 2024 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Oncobell Program, Bellvitge Biomedical Research Institute - IDIBELL, L'Hospitalet, Barcelona, Spain.
- Biomedical Research Networking Center in CIBER in Hepatic and Digestive Diseases (CIBEREHD), ISCIII, Madrid, Spain.
- Department of Physiological Sciences, Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain.
- Department of Physiology and Pharmacology, Faculty of Pharmacy, University of Salamanca, Salamanca, Spain.
- Centro de Investigación del Cancer and Instituto de Biología Molecular y Celular del Cancer, CSIC-Universidad de Salamanca, Salamanca, Spain.
- Department of Biochemistry and Molecular Biology, Faculty of Pharmacy, Complutense University of Madrid, Madrid, Spain.
ORCID-Profile: Javier Vaquero, Marta Gut, Isabel Fabregat
Förderung
- CIBEREHD, National Biomedical Research Institute on Liver and Gastrointestinal Diseases
- CERCA Programme/Generalitat de Catalunya
- Fundacion Ramon Areces
- Agencia Estatal de Investigación, Ministerio de Ciencia e Innovación, Spain
- European Regional Development Fund
- Instituto de Salud Carlos III
- Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas
- Generalitat de Catalunya
Zitieren
APA
Gonzalez-Sanchez, E., Vaquero, J., Caballero-Diaz, D., Grzelak, J., Fusté, N. P., Bertran, E., Amengual, J., Garcia-Saez, J., Martín-Mur, B., Gut, M., Esteve-Codina, A., Alay, A., Coulouarn, C., Calero-Perez, S., Valdecantos, P., Valverde, A. M., Sánchez, A., Herrera, B., & Fabregat, I. (2024). The hepatocyte epidermal growth factor receptor ( EGFR ) pathway regulates the cellular interactome within the liver fibrotic niche. The Journal of Pathology. https://doi.org/10.1002/path.6299
Vancouver
Gonzalez-Sanchez E, Vaquero J, Caballero-Diaz D, Grzelak J, Fusté NP, Bertran E, et al. The hepatocyte epidermal growth factor receptor ( EGFR ) pathway regulates the cellular interactome within the liver fibrotic niche. The Journal of Pathology. 2024. doi:10.1002/path.6299
BibTeX
@article{GonzalezSanchez2024,
author = {Gonzalez-Sanchez, Ester and Vaquero, Javier and Caballero-Diaz, Daniel and Grzelak, Jan and Fusté, Noel P and Bertran, Esther and Amengual, Josep and Garcia-Saez, Juan and Martín-Mur, Beatriz and Gut, Marta and Esteve-Codina, Anna and Alay, Ania and Coulouarn, Cedric and Calero-Perez, Silvia and Valdecantos, Pilar and Valverde, Angela M and Sánchez, Aránzazu and Herrera, Blanca and Fabregat, Isabel},
title = {The hepatocyte epidermal growth factor receptor ( EGFR ) pathway regulates the cellular interactome within the liver fibrotic niche},
journal = {The Journal of Pathology},
year = {2024},
doi = {10.1002/path.6299}
}
EUVIMED